George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksByotrol Regulatory News (BYOT)

Share Price Information for Byotrol (BYOT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.125
Bid: 0.05
Ask: 0.20
Change: 0.00 (0.00%)
Spread: 0.15 (300.00%)
Open: 0.125
High: 0.125
Low: 0.125
Prev. Close: 0.125
BYOT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First US Retail Trial with Target

17 May 2018 07:00

RNS Number : 3364O
Byotrol PLC
17 May 2018
 

 

 

17th May, 2018

Byotrol plc

("Byotrol" or the "Company") 

 

FURTHER PROGRESS IN THE US

 

MASS MARKET RETAIL TRIAL WITH TARGET

 

 

Byotrol plc, the specialist anti-microbial technology company, is pleased to announce that it has secured its first mass market retail trial in the US, for its 24-hour germ-kill surface sanitizer 'Byotrol24'.

 

The trial is due to take place over approximately 10-12 weeks at the national retailer Target. We are expecting the trial to start next month in approximately 10% of Target's 1,829 stores, following which Target will decide whether it wishes to roll-out into nationwide distribution.

 

This progress follows on closely from the Company having completed individual US State product registration earlier this month. Byotrol24 received formal approval from the US Environmental Protection Agency in June 2017.

 

 

 

David Traynor, Chief Executive of Byotrol plc comments:

 

"This is really good news for Byotrol. Target Corporation is one of the leading general merchandise retailers in the US and is well-known for innovation and design; it is a perfect retail match for our brand and an excellent first step in pursuing our US commercialisation ambitions."

 

 

 

Enquiries:

David Traynor - Chief Executive, Byotrol plc 01925 742 000

David Paton - Investor Relations 07714 190 474

 

 

finnCap Ltd 020 7220 0500 (Nominated Adviser & Broker)

Geoff Nash/Kate Bannatyne - Corporate Finance

Richard Chambers - Corporate Broking

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of residual antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial solutions.

 

Our patented suite of technologies deliver powerful broad-spectrum efficacy with residual performance optimised against commonly occurring and industry-specific pathogens.

 

Founded in 2005, the Company has developed advanced antimicrobial technologies that create easier, safer and cleaner lives for everyone.

 

For more information, please go to www.byotrol.co.uk

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTLLFIRELIRLIT
Date   Source Headline
14th Nov 20114:40 pmRNSHolding(s) in Company
11th Nov 20119:46 amRNSHolding(s) in Company
9th Nov 20113:30 pmRNSHolding(s) in Company
7th Nov 201110:06 amRNSResult of EGM
21st Oct 20117:00 amRNSIssue of Equity to raise £2.46m
16th Sep 20117:00 amRNSChange of Adviser
21st Jul 20114:10 pmRNSResult of AGM
20th Jul 20117:00 amRNSMulti Country Contract with Rentokil
28th Jun 20112:39 pmRNSAnnual Financial Report and AGM notice
27th Jun 201112:14 pmRNSHolding(s) in Company
24th Jun 201110:53 amRNSHolding(s) in Company
21st Jun 20117:00 amRNSPreliminary Results
11th May 20117:00 amRNSDevelopment Contract with Fortune 150 Company
7th Apr 20115:20 pmRNSHolding(s) in Company
8th Feb 20117:00 amRNSAgreement with McBride on European Licence
9th Dec 20107:00 amRNSLicence Agreement with makers of Tommee Tippee
30th Nov 20102:39 pmRNSDirector/PDMR Shareholding
16th Nov 20107:00 amRNSInterim Results
23rd Sep 20105:18 pmRNSHolding(s) in Company
3rd Sep 201010:12 amRNSHolding(s) in Company
31st Aug 201012:01 pmRNSResult of General Meeting
19th Aug 201012:50 pmRNSGrant of Options
11th Aug 20107:00 amRNSIssue of Equity
29th Jul 20103:33 pmRNSResult of AGM
7th Jul 20107:00 amRNSJDA in UK & Ireland and Agreement Extension in US
6th Jul 20102:18 pmRNSAnnual Report and Notice of AGM
30th Jun 20107:00 amRNSContract to supply Odour Elimination goods in USA
25th Jun 20103:41 pmRNSDirector/PDMR Shareholding
22nd Jun 20104:02 pmRNSDirector/PDMR Shareholding
15th Jun 20107:00 amRNS2010 Preliminary Results
28th May 20107:00 amRNSResearch Grant, Patent Grant & Directorate Change
13th Apr 20101:38 pmRNSDirector/PDMR Shareholding
13th Apr 201010:16 amRNSDirector/PDMR Shareholding
30th Mar 20102:42 pmRNSDirector/PDMR Shareholding
25th Mar 201010:00 amRNSTrading update and results date
25th Mar 201010:00 amRNSDirectorate Change
26th Feb 201012:52 pmRNSTotal Voting Rights
4th Feb 20109:42 amRNSAcquisition of ByoFresh
22nd Dec 200911:40 amRNSHolding(s) in Company
22nd Dec 200911:40 amRNSHolding(s) in Company
21st Dec 20097:00 amRNSUS Patent and Option Agreement
1st Dec 20097:00 amRNSSociety of Food Hygiene & Technology Award
20th Nov 20097:00 amRNSDirector/PDMR Shareholding
17th Nov 20097:00 amRNSInterim Results
6th Oct 20097:00 amRNSTrading Statement
29th Sep 200911:59 amRNSHolding(s) in Company
17th Sep 20097:00 amRNSTrading Statement
11th Aug 20099:47 amRNSHolding(s) in Company
5th Aug 20097:00 amRNSUpdate on current business
30th Jul 20094:46 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.